BA, MBA, CLP
Dave is Executive Director of the Michigan State University Foundation, a non-profit research foundation that funds and brings groundbreaking discoveries to market. Dave oversees the Foundation’s $500M endowment and drives the development of an innovation ecosystem at Michigan State. He serves as President of Spartan Innovations, MSU’s venture studio. He formed Red Cedar Ventures and the Michigan Rise Pre-Seed III Fund, overseeing $30M of early stage investment funds. Dave catalyzed the re-development of the University Health Park, a health campus anchored by a $600M hospital and cancer center. He is on the board of the LDFA, the MedTech Advisory Committee and served on the board of Michigan Economic Development Corporation. Dave was President & CEO of the University of Tennessee Research Foundation and a board member of Life Science Tennessee. He led the software commercialization practice at the University of Illinois and held management positions with Wolfram Research, InstallShield (acquired by Macrovision), and Kuck & Associates (acquired by Intel) and holds a BA and MBA from the University of Illinois at Urbana-Champaign.
Jock Holliman formed Valley Ventures in 1993 and has served as a General Partner in four private venture capital partnerships aggregating approximately $94 million in committed institutional capital. Valley’s investment strategy focused on early-stage information and life science technologies in the Southwestern United States with a focus in Arizona. All Valley investments have been liquidated and distributed to partners.
Prior to Valley Ventures, Jock led the venture capital effort at Valley National Bank of Arizona from 1985 to 1992. He previously held corporate bank lending positions at Bank of America and Chemical Bank – New York.
Jock holds undergraduate and Masters business degrees from Southern Methodist University in Dallas, as well as a Masters degree in International Management from the Thunderbird School of International Management in Phoenix. Jock has served on the boards of directors of approximately 45 private and public companies.
Dr. Barbara Wirostko, a serial entrepreneur, is the Chief Medical Officer and Co-Founder of Qlaris Bio. Dr. Wirostko is a board-certified practicing glaucoma specialist holding a Clinical Adjunct Professor position at the University of Utah, in Ophthalmology at Moran Eye Center and in the Dept. of Biomedical Engineering. She was previously the Chief Medical Officer of EyeGate Pharmaceuticals following its acquisition of Jade Therapeutics where Dr. Wirostko was Co-Founder and Chief Scientific Officer spearheading the strategy and operations for the preclinical and clinical development of the unique hyaluronic acid, Ocular Bandage Gel (OBG), for human use. For Jade Therapeutics, Dr Wirostko received upwards of 3 M in SBIR funding as the Principle Investigator for the OBG polymer from the Dept of Defense and National Science Foundation. Prior to Jade, she served as the Chief Medical Officer of Altheos, a glaucoma startup company, and held leadership positions in medical and clinical development at Pfizer in Ophthalmology, overseeing the global medical responsibilities for the Xalatan franchise as Senior Medical Director. She sits on various editorial boards including the prestigious Ophthalmology Glaucoma and Journal of Glaucoma, has published and written hundreds of peer reviewed papers, books, serves on numerous advisory boards, grant review committees, and holds fellowship positions with The Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.
She has been invited globally to lecture on her area of clinical research expertise, exfoliation glaucoma. Dr. Wirostko received her MD from and completed her residency at Columbia University, College of Physicians and Surgeons, NY, and holds a BA with distinction in Microbiology from Cornell University.
Following the death of their oldest son, Dr. Wirostko with her husband Dr. Joseph Morelli founded a nonprofit for young students with learning challenges. Started in 2014, under Dr. Wirostko’s directorship, the Joseph James Morelli Legacy Foundation is now a nationally recognized 501c3, having awarded 100s of students’ scholarships around the country, to help recognize and advocate for dyslexia. Her outreach and advocacy have included a TedX talk in April 2019 on the story of Joseph. Dr. Wirostko currently lives in Park City, Utah with her husband and children, enjoying skiing and the outdoors.
Mark serves as Executive Chairman and Director of Clarus Therapeutic. After receiving his B.S. in Accounting from Pace University, he has spent nearly three decades in the pharmaceutical industry. He has served as board member for numerous companies within the healthcare industry, and as former President, he led Medicis from a start-up to a company that sold for approximately $2.6 billion.
BA, MBA Candidate
Mike received his BA from the University of Arizona in 2012. He then served as director of FindUrgentCare.com and managed Urgent Care Integrated Network’s sales team. Mike has also founded multiple small businesses such as WantSomeSoda and Castellini Design. In 2014, Mike joined the United States Air Force where he serves as an A-10C Warthog Fighter/Instructor Pilot. After a successful Combat deployment, Mike transitioned to a part time military status. Mike is currently an MBA candidate at ASU’s W.P. Carey School of Business focusing on Finance and Entrepreneurship.
JD, BA Economics, Communications
Hannah Vice is Yoo & Co Accelerators’ General Counsel & Director of Corporate Development, where she helps accelerator startups in the portfolio establish corporate operations and efficient strategic decision making. Hannah’s past healthcare experience includes working in the public sector, where she managed contract lifecycles and large-scale projects. In the startup realm, Hannah’s operations and legal background bring a unique perspective to her responsibilities including strategic operations, legal operations and strategy, digital transformation initiatives, and team development. Hannah was most recently Director of Operations for Systems Imagination, a big data analytics company providing faster insights for pharmaceutical research. Hannah received her J.D. from Sandra Day O’Connor College of Law at ASU and her dual B.A.’s in Economics and Communications from the University of Nevada.
B.S. Business Administration, Accounting
A rising finance leader, TJ Kline has guided a number of growing and mature healthcare organizations into rapid business growth and high financial performance. Early in his career, he led accounting operations for telemedicine startup MeMD Inc. before the company’s acquisition by WalMart Health; at Landmark Recovery, he managed the accounting department during the successful expansion of a single addiction treatment facility into ten facilities spanning seven states. As finance manager of Tribal Health, he has helped enable a staffing increase at Native American healthcare facilities by more than 300 percent. He has also provided accounting and finance services for Empower Emergency Physicians, Landmark Senior Living, USCareways, Van Ness Development, and Derbyshire Real Estate. Kline has a proven track of ensuring compliance, enhancing operational efficiency, and accelerating business growth.
Yvette Ferreira is Yoo & Co Accelerators’ Director of Market Development, where she provides guidance and expertise to accelerator startups in the development of highly effective, revenue generating marketing and customer acquisition strategies. Yvette brings over 15 years of healthcare and life sciences industry experience to the company. As a former account executive with several Fortune 500 pharmaceutical companies, her domain expertise spans multiple disease specialties, including Neurology and Oncology. Yvette has worked with several startups in various roles including program management, sales operations, marketing, and strategic partnerships. She has been instrumental in the development of processes and strategy execution. Yvette was most recently Director of Market Development for Systems Imagination. Yvette received her B.S. in Finance from Rutgers Business School.
MD, JD, MBA, FACEP
John received his BA from Drake and his MD from the Rosalind Franklin. He completed his Emergency Medicine Residency at Christ Hospital where he was Chief Resident. John received his MBA in 1995, and his JD in 2005, both from ASU. In 2015, he completed his Six Sigma Black Belt from the Fulton School of Engineering. In 2019 he completed a certificate program in Artificial Intelligence at MIT. He founded NextCare Inc. in 1993 as well as numerous other health and non-health care businesses. He is the business manager and one of the founding partners of Empower Emergency Physicians and continues to practice emergency medicine. In 2010, John founded MeMD. MeMD is used by more than 500 providers in 50 states to virtually treat patients on-demand. MeMD sold to Walmart in June, 2021. In 2015, John founded Tribal EM, an emergency medicine staffing and management company dedicated to improving the delivery of healthcare for Indigenous People. He has authored 12 books on business, personal growth, leadership, and urgent care medicine and management.
Chris has over 25 years of experience in advancing cutting-edge biomedical information technology in the Healthcare & Life Sciences industry. Chris most recently operated Yoo & Co Accelerators, the premier business accelerator in Arizona for healthcare & life sciences startups. Chris is an active angel investor and, as a serial entrepreneur, has created value in new companies that accelerate the adoption of smarter, technology-based systems such as cognitive computing, big data analytics, and systems engineering. Some of his prior ventures include Systems Oncology, an oncology biotechnology company, Systems Imagination, a pioneer in advanced cognitive computing for drug discovery, and MedTrust Online, the world’s first and largest online community of cancer doctors. He has also developed some of the earliest solutions and strategies in personalized medicine for companies such as Cisco, Applied Biosystems, Oracle, and IBM. Chris participates on the boards of several companies where he enjoys working arm-in-arm with the next generation of entrepreneurs and innovators. Chris is faculty at Arizona State University and Grand Canyon University teaching courses in molecular diagnostics and in entrepreneurship. He completed a postdoctoral fellowship at UC Berkeley, his PhD in Cell and Molecular Biology from Yale University School of Medicine, and a B.S. in History and Biology from the University of Pennsylvania.